Hosted on MSN15d
Tirzepatide, Semaglutide Not Cost-Effective at Current Prices
WEDNESDAY, March 19, 2025 (HealthDay News) -- Tirzepatide and semaglutide offer long-term health benefits but are not cost-effective, according to a study published online March 14 in JAMA Health ...
Hosted on MSN2mon
Semaglutide currently not cost-effective for heart patients without diabetes, study finds
semaglutide is not cost-effective. However, with price reductions or rebates of up to 50%, semaglutide could meet the benchmark for value in health care." The study's decision analysis entailed ...
Healio21d
Semaglutide, tirzepatide not deemed cost-effective obesity therapies despite benefits
In findings from a microsimulation model published in JAMA Health Forum, semaglutide (Wegovy, Novo Nordisk) had the highest incremental cost-effectiveness ratio (ICER) of four obesity medications ...